Who we are ?

Smilax Laboratories Limited is a fully backward integrated Active Pharmaceutical Ingredients manufacturing company catering to the generics market across the world. Smilax’s current standing is the outcome of its cutting-edge research, world class manufacturing, and truly global supply chain management.

Since its incorporation in 2004, Smilax has grown to become a reliable supplier of generic API products in the global market. Smilax supports entrepreneurial spirit, culture of creativity and innovation that makes the difference in the lives of people.

Our Products

A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. We offer high-quality, affordable generic medications that help reduce healthcare costs around the world.

APIs

API Intermediates

Pellets and DC Granules

CDMO & CMO

Our Strengths

20 Years of API Manufacturing Excellence

Promoted by US$ 2billion Ramky Group

100+ Products across APIs, Intermediates and Pellets

Built up Area of 370,000 SFT

475 KL multipurpose multiple block facilities

Plans to scale-up to 1200 KL

Well-equipped R&D Centre with 60+ Scientists

Regulatory Approvals : USFDA, EU-GMP and PMDA Japan

Our Capabilities

Smilax labs Infrastructure

Smilax's manufacturing facilities are one of its key differentiators. The Company currently operates from two commercial multi-product facilities located at Hyderabad and Visakhapatnam that are designed to meet all the requirements of cGMP

Click Here

Get in Touch with us

Fill the form, we will contact you asap